Effect of tyrosine kinase inhibitors on regulatory T-cells (tregs) in patients with chronic myeloid leukemica (CML)

Result code in IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61989592%3A15110%2F08%3A10224405" target="_blank" >RIV/61989592:15110/08:10224405 - isvavai.cz</a>

Result on the web

—

DOI - Digital Object Identifier

—

Result language

angličtina

Original language name

Effect of tyrosine kinase inhibitors on regulatory T-cells (tregs) in patients with chronic myeloid leukemica (CML)

Original language description

Tyrosine kinase inhibotors (TKIs) are currently the standard treatment in patients with chronic myeloid leukemia (CML). In addition to BCR-ABL oncoprotein, they also inhibit other kinases (e.g. C-kit, TEC, BTK, PDGFR, SRC), some of which have important physiological functions in immune responses. however, the in vivo effects of TKIs on immune effector cells are mostly unknown.

Czech name

—

Czech description

—

Type

J_x - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)

CEP classification

FD - Oncology and haematology

OECD FORD branch

—

Project

—

Continuities

I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Publication year

2008

Confidentiality

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Name of the periodical

Haematologica: the hematology journal

ISSN

0390-6078

e-ISSN

—

Volume of the periodical

93

Issue of the periodical within the volume

1

Country of publishing house

IT - ITALY

Number of pages

2

Pages from-to

44-45

UT code for WoS article

—

EID of the result in the Scopus database

—